Back to Results
First PageMeta Content
Gynaecological cancer / Vaccines / Viral diseases / Carcinogens / Human papillomavirus / Cervical screening / HPV vaccine / Cervical cancer / Pap test / Medicine / Papillomavirus / Oncology


aroundtheindustry In Vitro Diagnostics Can E6E7 Alter The Competitive Balance In The Crowded HPV Test Market?
Add to Reading List

Document Date: 2011-12-23 05:21:33

Open Document

File Size: 159,18 KB

Share Result on Facebook

Company

Qiagen NV / Ventana Medical Systems Inc. / IncellDx Inc. / Institut Merieux’s bioMerieux SA. / Digene Corp. / Abbott Laboratories Inc. / Arbor Vita Corp. / Roche / Becton Dickinson & Co. / OncoHealth Corp. / Hologic Inc. / Third Wave Technologies Inc. / 2007 Qiagen NV / Norchip AS / Blockbuster / Cytyc Corp. / /

Country

Norway / United States / /

Currency

USD / /

Event

FDA Phase / M&A / /

Facility

Wolfson Institute of Preventive Medicine / /

IndustryTerm

Cancer Prevention / /

MedicalCondition

viral infection / cervical cancer disease / HPV infection / accurate and sensitive primary cervical cancer / cancer / disease / HPV / cervical cancer / cervical carcinoma / cervical intraepithelial neoplasia / human papilloma virus / /

MedicalTreatment

invasive procedure / /

Organization

Wolfson Institute of Preventive Medicine / FDA / International Criminal Court / Centre for Cancer Prevention / /

Person

Shuling Cheng / Winnie Wan / Mark L. Ratner / Jack Cuzick / /

Position

head / CEO / current strategic player / cytology specialist / /

Product

Invader platform / E6E7 / Invader / /

ProvinceOrState

California / /

PublishedMedium

Elsevier / The Business / /

Technology

antibodies / In Vitro Diagnostics / /

URL

www.ElsevierBI.com / /

SocialTag